Good Neighbor Pharmacy Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet, 30-count — NDC 46122-337-65 (Billing 46122-0337-65)
by AmerisourceBergen Drug Corp · 1 BLISTER PACK in 1 CARTON / 30 TABLET in 1 BLISTER PACK
This is a package of 30 tablets of Good Neighbor Pharmacy Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet from AmerisourceBergen Drug Corp, marketed since Jan 2016 and currently FDA-listed; retail pharmacies pay about $0.1316 per tablet (NADAC). It is this product's only package size.
NDC 46122-0337-65
🏷️ FDA NDC (as labeled)
46122-337-65
billing pads the product segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 46122-337-65 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 46122 labeler · 337 product · 65 package
- Package marketed since
- Jan 28, 2016
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Billing quantity
- 30 EA per package
- Barcode (UPC)
- 0087701427213
- Medicaid fills, this package
- 171 prescriptions in the last four reported quarters
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
46122-337-65
Product NDC
46122-337
11-digit billing NDC
46122033765
NCPDP billing unit
EA — each (per item)
RxCUI
1094126
UNII
0EWG668W17
UPC
0087701427213
SPL Set ID
f0b13011-30dc-48ef-ae65-999074a35d7c
DEA schedule
Non-controlled
Marketing category
UNAPPROVED DRUG OTHER
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2016-01-28
Route
ORAL
Dosage form
TABLET
Substance
PHENAZOPYRIDINE HYDROCHLORIDE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
56300010100303
GPI class
GNP Urinary Pain Relief
GCN Seq No
016828
GCN
42123
HICL code
004108
Ingredient (HICL)
Phenazopyridine Hcl
HIC1 code
R
Therapeutic class — broad (HIC1)
Kidney/Urinary Tract
HIC2 code
R5
Therapeutic class — intermediate (HIC2)
Urinary Tract Anesthetic/Analgesic Agents
HIC3 code
R5A
Therapeutic class — specific (HIC3)
Urinary Tract Anesthetic/Analgesic Agnt (Azo-Dye)
AHFS code
84:08.00.00
AHFS class
Antipruritics And Local Anesthetics
FDB label name
URINARY PAIN RELIEF 95 MG TAB
FDB brand name
Urinary Pain Relief
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 016828
- GCN: 42123
- GPI-14 (Medi-Span): 56300010100303
- HICL (First Databank): 004108
- AHFS class code: 84:08.00.00
- RxCUI (RxNorm): 1094126
Why two NDCs?
The FDA registers this code as 46122-337-65 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0337-65. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the Other urologicals class.
Drug family (ATC)
Other urologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Label name URINARY PAIN RELIEF 95 MG TAB Ingredient Phenazopyridine Hcl
📗 Our plain-language guide HelloPharmacist
- It only helps with the pain — it doesn't kill the bacteria causing the infection. Think of it as taking the edge off while your antibiotic does the real work. If you have a UTI, yo...
- Does phenazopyridine actually treat my UTI, or does it just help with the pain?
- That's completely expected with phenazopyridine — it's one of the most common things people notice. The drug itself has an orange-red dye, and it passes into your urine, which is w...
- Why is my urine turning orange or red? Should I be worried?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
💬 Questions about PHENAZOPYRIDINE HYDROCHLORIDE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.132 | $3.95 / 30 tablets |
| Medicaid paysCMS SDUD · 12 mo | $0.3220 | $9.66 / 30 tablets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▲ Up 13% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file · file of Oct 7, 2026
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q1 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 46122-0337-65 You're viewing this Main listing | 1 BLISTER PACK in 1 CARTON / 30 TABLET in 1 BLISTER PACK | 2016-01-28 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Quality Choice Urinary Pain Relief 95 mg 63868-0117-30 | Chain | 30 tablets | $0.118 | — | FDA listed | save 10% |
| HealthMart Urinary Pain Relief 95 mg 62011-0325-01 | Strategic | 30 tablets | $0.120 | — | FDA listed | save 9% |
| Rugby Phenazopyridine HCl Urinary Tract Analgesic 95 mg 00536-1411-07 | Rugby | 30 tablets | $0.132 | — | Availability likely | — |
| Good Neighbor Pharmacy Urinary Pain Relief 95 mgthis 46122-0337-65 | AmerisourceBergen | 30 tablets | $0.132 | — | Availability likely | — |
| Uro-Pain 95 mg 57237-0331-03 | Rising | 30 tablets | $0.132 | — | Availability likely | — |
| Leader Urinary Pain Relief 95 mg 70000-0243-01 | Cardinal | 30 tablets | $0.132 | — | Availability likely | — |
| Foster and Thrive Neighbor Pharmacy Urinary Pain Relief 95 mg 70677-1229-01 | Strategic | 30 tablets | $0.132 | — | Availability likely | — |
| Sunmark Urinary Pain Relief 95 mg 49348-0076-44 | Strategic | 30 tablets | $0.132 | — | Availability likely | +0% |
| Walgreens Urinary Pain Relief 95 mg 00363-7775-30 | Walgreens | 30 tablets | — | — | FDA listed | — |
| CVS Health Urinary Pain Relief 95 mg 10956-0001-30 | Reese | 30 tablets | — | — | FDA listed | — |
| Preferred Urinary Pain Relief 95 mg 10956-0551-30 | Reese | 30 tablets | — | — | FDA listed | — |
| Rite Aid Urinary Pain Relief 95 mg 11822-8855-06 | Rite | 30 tablets | — | — | FDA listed | — |
| Kroger Urinary Pain Relief 95 mg 30142-0564-30 | THE | 30 tablets | — | — | FDA listed | — |
| TopCare Urinary Pain Relief 95 mg 36800-0040-30 | TOPCO | 30 tablets | — | — | FDA listed | — |
| Skopko Urinary Pain Relief 95 mg 37012-0098-01 | Skopko | 32 tablets | — | — | FDA listed | — |
| Azo 95 mg 49973-0301-31 | i-Health, | 30 tablets | — | — | FDA listed | — |
| Phenazopyridine Hydrochloride 95 mg 68071-2273-03 | NuCare | 30 tablets | — | — | FDA listed | — |
| Good Neighbor Pharmacy Urinary Pain Relief 95 mg 71205-0584-30 | Proficient | 30 tablets | — | — | FDA listed | — |
| Quality Choice Urinary Pain Relief 95 mg 83324-0201-30 | Chain | 30 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file · file of Oct 7, 2026
Availability & generic status
🏛️
2016
On the market since
Jan 2016
📍
2026
Currently FDA-listed
10 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Phenazopyridine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII J2B2A4N98G
Lactose is a natural sugar derived from milk. In medications, it serves as a filler and binder to add bulk and help hold tablet or capsule ingredients together during manufacturing.
-
UNII 9B9691B2N9
Magnesium silicate is a mineral compound used in tablets and capsules as a glidant and anti-caking agent. It helps powder ingredients flow smoothly during manufacturing and prevents clumping in the final product.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 46N107B71O
Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
-
UNII AG9B65PV6B
A starch derivative made from corn that helps tablets and capsules break apart quickly when swallowed. It acts as a disintegrant, allowing the medicine to dissolve and be absorbed in your stomach and intestines.
7 inactive ingredients listed in the exact product block matched to this NDC.
The official label also stateslactose, magnesium silicate, magnesium stearate, microcrystalline cellulose, pharmaceutical glaze, and sodium starch glycolate. May also contain: corn starch, croscarmellose sodium, polyvinylpyrrolidone, pregelatinized starch and silicon dioxide.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerAmerisourceBergen Drug Corp
Labeler code46122
First marketedJan 2016
Product typeHuman Otc Drug
Portfolio13 products on file
More NDCs from AmerisourceBergen Drug Corp labeler code 46122
- good neighbor pharmacy omeprazole 20 mg Tablet, Delayed Release NDC 46122-281-04
- Good Neighbor Pharmacy Pain Relief Acetaminophen 500 mg Tablet, Film Coated NDC 46122-312-62
- good neighbor pharmacy pain and fever childrens Acetaminophen 160 mg/5mL Suspension NDC 46122-322-26
- GNP Isopropyl Rubbing Alcohol 70 Percent 700 mg/mL Liquid NDC 46122-330-43
- GNP Isopropyl Alcohol 70 Percent With Wintergreen Oil 700 mg/mL Liquid NDC 46122-331-43
- GNP Witch Hazel 855 mg/mL Liquid NDC 46122-335-43
- Good Neighbor Pharmacy Dual Action Complete famotidine, calcium carbonate and magnesium hydroxide 10 mg; 800 mg; 165 mg Tablet, Chewable NDC 46122-345-63
- Nicotine Transdermal System 14 mg/24h Patch, Extended Release NDC 46122-352-74
- Nicotine Transdermal System 21 mg/24h Patch, Extended Release NDC 46122-353-74
- Nicotine Transdermal System 7 mg/24h Patch, Extended Release NDC 46122-354-74
- Salicylic Acid Liquid Wart Remover .17 g/9mL Liquid NDC 46122-362-29
- Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release NDC 46122-383-22
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Ask a Doctor Before Use If
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
🤰 If Pregnant or Breast-Feeding
📄 Keep Out of Reach of Children
🎯 Indications and Usage ▾
Uses fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.
⏱️ Dosage and Administration ▾
Directions ■ Adults and children 12 and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed ■ Children under 12: consult a doctor ■ Do not use for more than 2 days (12 tablets) without consulting a doctor
⚠️ Warnings ▾
Warning Do not exceed recommended dosage
🧪 Active Ingredient ▾
Active Ingredient Phenazopyridine Hydrochloride 95 mg
🧪 Inactive Ingredients ▾
Inactive Ingredients lactose, magnesium silicate, magnesium stearate, microcrystalline cellulose, pharmaceutical glaze, and sodium starch glycolate. May also contain: corn starch, croscarmellose sodium, polyvinylpyrrolidone, pregelatinized starch and silicon dioxide. image of carton
🎯 Purpose ▾
Purpose Urinary Analgesic
📄 Ask a Doctor Before Use If ▾
Ask Doctor before use if you have ■ kidney disease ■ allergies to foods, preservatives or dyes ■ had a hypersensitive reaction to Phenazopyridine
📄 When Using This Product ▾
When using this product ■ When using this product stomach upset may occur, taking this product with or after meals may reduce stomach upset ■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if ■ your symptoms last for more than 2 days ■ you suspect you are having an adverse reaction to the medication
🤰 If Pregnant or Breast-Feeding ▾
If pregnant or breast feeding ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of the reach of children in case of an overdose,get medical help or contact a Poison Control Center right away.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
171
Units reimbursed last 4 qtrs
3.9K
Gross reimbursed last 4 qtrs
$1.2K
Avg / prescription
$7.25
Avg / unit
$0.3220
Latest quarter Q1 2026
20Rx
Medicaid pays / ea
$0.3220
gross reimbursed
vs
NADAC / ea
$0.1316
acquisition cost
=
Spread
+$0.1904
+145% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 0 Rx Managed care · 171 Rx
State Medicaid map
Units reimbursed · per 100k residents
4.4111
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
About this NDC listing & data coverage
Over-the-counter (OTC) product
Marketed without an FDA application
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | ✓ Available |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by AmerisourceBergen Drug Corp. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
AmerisourceBergen Drug Corp is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.